Flexible Subscriptions to Match your Budget and Timeline See Plans and Pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
Mallinckrodt
AstraZeneca
Express Scripts
McKesson
Medtronic

Last Updated: June 27, 2022

Amoxicillin; omeprazole magnesium; rifabutin - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard

What are the generic sources for amoxicillin; omeprazole magnesium; rifabutin and what is the scope of patent protection?

Amoxicillin; omeprazole magnesium; rifabutin is the generic ingredient in one branded drug marketed by Redhill and is included in one NDA. There are five patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Amoxicillin; omeprazole magnesium; rifabutin has twenty-nine patent family members in twenty-four countries.

One supplier is listed for this compound.

Summary for amoxicillin; omeprazole magnesium; rifabutin
International Patents:29
US Patents:5
Tradenames:1
Applicants:1
NDAs:1
Finished Product Suppliers / Packagers: 1
DailyMed Link:amoxicillin; omeprazole magnesium; rifabutin at DailyMed

US Patents and Regulatory Information for amoxicillin; omeprazole magnesium; rifabutin

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
Redhill TALICIA amoxicillin; omeprazole magnesium; rifabutin CAPSULE, DELAYED RELEASE;ORAL 213004-001 Nov 1, 2019 RX Yes Yes See Plans and Pricing See Plans and Pricing Y See Plans and Pricing
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

International Patents for amoxicillin; omeprazole magnesium; rifabutin

Country Patent Number Title Estimated Expiration
Singapore 11201506318Q PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI See Plans and Pricing
South Korea 20150118176 헬리코박터 파일로리 치료용 약제학적 조성물 (PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI) See Plans and Pricing
European Patent Office 2956149 COMPOSITIONS PHARMACEUTIQUES DESTINÉES AU TRAITEMENT D'HELICOBACTER PYLORI (PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HELICOBACTER PYLORI) See Plans and Pricing
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

McKesson
AstraZeneca
Harvard Business School
Johnson and Johnson
Dow
Medtronic

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.